379 related articles for article (PubMed ID: 33671197)
1. The Multiomics Analyses of Fecal Matrix and Its Significance to Coeliac Disease Gut Profiling.
Gangadoo S; Rajapaksha Pathirannahalage P; Cheeseman S; Dang YTH; Elbourne A; Cozzolino D; Latham K; Truong VK; Chapman J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671197
[TBL] [Abstract][Full Text] [Related]
2. The Host Shapes the Gut Microbiota via Fecal MicroRNA.
Liu S; da Cunha AP; Rezende RM; Cialic R; Wei Z; Bry L; Comstock LE; Gandhi R; Weiner HL
Cell Host Microbe; 2016 Jan; 19(1):32-43. PubMed ID: 26764595
[TBL] [Abstract][Full Text] [Related]
3. Challenges of metabolomics in human gut microbiota research.
Smirnov KS; Maier TV; Walker A; Heinzmann SS; Forcisi S; Martinez I; Walter J; Schmitt-Kopplin P
Int J Med Microbiol; 2016 Aug; 306(5):266-279. PubMed ID: 27012595
[TBL] [Abstract][Full Text] [Related]
4. An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection.
Antharam VC; McEwen DC; Garrett TJ; Dossey AT; Li EC; Kozlov AN; Mesbah Z; Wang GP
PLoS One; 2016; 11(2):e0148824. PubMed ID: 26871580
[TBL] [Abstract][Full Text] [Related]
5. Optimization of an in vitro gut microbiome biotransformation platform with chlorogenic acid as model compound: From fecal sample to biotransformation product identification.
Mortelé O; Iturrospe E; Breynaert A; Verdickt E; Xavier BB; Lammens C; Malhotra-Kumar S; Jorens PG; Pieters L; van Nuijs ALN; Hermans N
J Pharm Biomed Anal; 2019 Oct; 175():112768. PubMed ID: 31398630
[TBL] [Abstract][Full Text] [Related]
6. Proteomics and the microbiome: pitfalls and potential.
Lin H; He QY; Shi L; Sleeman M; Baker MS; Nice EC
Expert Rev Proteomics; 2019 Jun; 16(6):501-511. PubMed ID: 30223687
[No Abstract] [Full Text] [Related]
7. Dietary Gluten-Induced Gut Dysbiosis Is Accompanied by Selective Upregulation of microRNAs with Intestinal Tight Junction and Bacteria-Binding Motifs in Rhesus Macaque Model of Celiac Disease.
Mohan M; Chow CT; Ryan CN; Chan LS; Dufour J; Aye PP; Blanchard J; Moehs CP; Sestak K
Nutrients; 2016 Oct; 8(11):. PubMed ID: 27801835
[TBL] [Abstract][Full Text] [Related]
8. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
9. Microbiome-related metabolite changes in gut tissue, cecum content and feces of rats treated with antibiotics.
Behr C; Sperber S; Jiang X; Strauss V; Kamp H; Walk T; Herold M; Beekmann K; Rietjens IMCM; van Ravenzwaay B
Toxicol Appl Pharmacol; 2018 Sep; 355():198-210. PubMed ID: 30008377
[TBL] [Abstract][Full Text] [Related]
10. An overview of fecal sample preparation for global metabolic profiling.
Deda O; Gika HG; Wilson ID; Theodoridis GA
J Pharm Biomed Anal; 2015 Sep; 113():137-50. PubMed ID: 25812436
[TBL] [Abstract][Full Text] [Related]
11. Reliability of a participant-friendly fecal collection method for microbiome analyses: a step towards large sample size investigation.
Szopinska JW; Gresse R; van der Marel S; Boekhorst J; Lukovac S; van Swam I; Franke B; Timmerman H; Belzer C; Arias Vasquez A
BMC Microbiol; 2018 Sep; 18(1):110. PubMed ID: 30189859
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiome changes in overweight male adults following bowel preparation.
Chen HM; Chen CC; Chen CC; Wang SC; Wang CL; Huang CH; Liou JS; Liu TW; Peng HL; Lin FM; Liu CY; Weng SL; Cheng CJ; Hung YF; Liao CC; Huang HD
BMC Genomics; 2018 Dec; 19(Suppl 10):904. PubMed ID: 30598081
[TBL] [Abstract][Full Text] [Related]
13. Unbiased Microbiome and Metabolomic Profiling of Fecal Samples from Patients with Melanoma.
Bui A; Choi Y; Frankel AE; Koh AY
Methods Mol Biol; 2021; 2265():461-474. PubMed ID: 33704734
[TBL] [Abstract][Full Text] [Related]
14. Progress of analytical tools and techniques for human gut microbiome research.
Song EJ; Lee ES; Nam YD
J Microbiol; 2018 Oct; 56(10):693-705. PubMed ID: 30267313
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs Regulate Intestinal Immunity and Gut Microbiota for Gastrointestinal Health: A Comprehensive Review.
Bi K; Zhang X; Chen W; Diao H
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32932716
[TBL] [Abstract][Full Text] [Related]
16. [Why could gut microbiota become a medication?].
Bourlioux P; Megerlin F; Corthier G; Gobert JG; Butel MJ
Ann Pharm Fr; 2014 Sep; 72(5):325-9. PubMed ID: 25220228
[TBL] [Abstract][Full Text] [Related]
17. Regional Diversity of the Gastrointestinal Microbiome.
Martinez-Guryn K; Leone V; Chang EB
Cell Host Microbe; 2019 Sep; 26(3):314-324. PubMed ID: 31513770
[TBL] [Abstract][Full Text] [Related]
18. Faecal microRNAs: indicators of imbalance at the host-microbe interface?
Moloney GM; Viola MF; Hoban AE; Dinan TG; Cryan JF
Benef Microbes; 2018 Feb; 9(2):175-183. PubMed ID: 29264965
[TBL] [Abstract][Full Text] [Related]
19. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
[TBL] [Abstract][Full Text] [Related]
20. Therapies to modulate gut microbiota: Past, present and future.
Gupta A; Saha S; Khanna S
World J Gastroenterol; 2020 Feb; 26(8):777-788. PubMed ID: 32148376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
